Introduction: Kawasaki disease (KD) is acute systemic vasculitis predominantly affecting children under 5 years of age (1). It can lead to serious cardiovascular complications, particularly coronary artery aneurysms, if not diagnosed and treated promptly (1). Classical KD is identified by a combination of persistent fever, mucocutaneous changes, ex

Introduction: Kawasaki disease (KD) is an acute, self-limited medium-vessel vasculitis with a marked affinity for the coronary arteries, most commonly affecting infants and young children (1). Although its exact cause remains unclear, KD is thought to arise from an exaggerated immune response in genetically predisposed individuals (1). Because of i

Introduction: Kawasaki disease (KD) is an acute inflammatory vasculitis that primarily affects infants and young children, with most cases occurring before five years of age (1). Although KD is treatable, delays in diagnosis can lead to coronary artery dilation and aneurysms, making early recognition essential (1). Because there is no single confir

We are pleased to invite you to join our upcoming interactive webinar titled “New Standards for RSV Protection in Infants.” This live session will bring together leading pediatric and public health experts to share the latest clinical insights, evidence-based strategies, and practical guidance on preventing RSV-related complications in infants. Our

Domestic Practice Malaysian doctors have many local options. In the public sector, positions range from permanent roles in government hospitals/clinics to short-term contract or locum tenens shifts. (The government is even moving contract doctors into permanent posts to curb brain drain (1).) In private practice, doctors can join established clinic

Vaccinations Ensure patients are up-to-date on routine shots (MMR, Tdap, polio, influenza, etc.) before any trip (1). Recommend destination-specific vaccines: for example, the Yellow Fever vaccine is required (with a valid certificate) for travel to risk countries, ideally administered ≥10 days before departure (2). Other recommended vaccines may i

In this insightful interview, Dr. Nikhil Ganjoo, a Consultant Pediatrician from Dubai, shares real-world experiences of how genomics is revolutionizing pediatric diagnosis and treatment. Discover how genetic insights are shaping patient care and guiding more precise, personalized interventions. What’s Covered: Memorable cases where genomic testing

Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine.  FDA Approval for Thymidine Kinase 2 Deficiency Treatment The FDA has approved doxecitine and doxribtimine, marking the first approved therapy for thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with symptom onset at

Introduction Neonatal jaundice continues to be one of the most common and closely monitored conditions in newborn care (1). Affecting nearly 60 percent of term and 80 percent of preterm infants, it often represents a physiological adaptation to extrauterine life (1). Yet, in certain cases, the accumulation of bilirubin can cross the threshold from